Location History:
- Chula Vista, CA (US) (2012)
- San Diego, CA (US) (2002 - 2023)
Company Filing History:
7 out of 14 
2 out of 10 
1 out of 1,179 
Years Active: 2002-2023
Title: The Innovative Contributions of John S. Tyhonas
Introduction
John S. Tyhonas is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 15 patents, he has made strides in developing innovative treatments for various diseases.
Latest Patents
Among his latest patents are the "Inhibitors of Raf Kinases," which provide pharmaceutical compositions comprising compounds that inhibit receptor tyrosine kinase effector, RAF. These compounds are designed for the treatment of diseases. Another notable patent is the "Inhibitors of MET Kinase," which includes pharmaceutical compositions that utilize MET receptor tyrosine kinase inhibitory compounds for disease treatment.
Career Highlights
Throughout his career, John has worked with Kinnate Biopharma Inc., where he has played a crucial role in advancing therapeutic solutions. His expertise in kinase inhibitors has positioned him as a key figure in the pharmaceutical industry.
Collaborations
John has collaborated with notable professionals in his field, including Toufike Kanouni and Stephen W. Kaldor. Their combined efforts have contributed to the development of innovative treatments and advancements in pharmaceutical research.
Conclusion
John S. Tyhonas exemplifies the spirit of innovation in the pharmaceutical industry through his extensive patent portfolio and collaborative efforts. His work continues to impact the treatment of diseases, showcasing the importance of inventors in advancing healthcare solutions.